Treatment of NAFLD and NASH
US11179359B2 · kind B2 · utility
0Cited by
21References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 19, 2020 |
| Grant date | Nov 23, 2021 |
| Priority date | — |
| Expiry date | Jun 19, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Treatment of NAFLD and NASH by therapy with MBX-8025 or an MBX-8025 salt.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.